These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 15901902

  • 1. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis.
    Korendowych E, Owen P, Ravindran J, Carmichael C, McHugh N.
    Rheumatology (Oxford); 2005 Aug; 44(8):1056-60. PubMed ID: 15901902
    [Abstract] [Full Text] [Related]

  • 2. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y, Zhang J, Chen YM, Guan M, Zheng SG, Zou HJ.
    Scand J Rheumatol; 2008 Aug; 37(3):183-7. PubMed ID: 18465452
    [Abstract] [Full Text] [Related]

  • 3. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.
    Bang SY, Lee KH, Cho SK, Lee HS, Lee KW, Bae SC.
    Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396
    [Abstract] [Full Text] [Related]

  • 4. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis.
    Candia L, Marquez J, Gonzalez C, Santos AM, Londoño J, Valle R, Zabaleta J, Yaqub Z, Espinoza LR.
    J Clin Rheumatol; 2006 Oct; 12(5):226-9. PubMed ID: 17023808
    [Abstract] [Full Text] [Related]

  • 5. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D, Anouk M, Golan I, Paran D, Kaufman I, Wigler I, Levartovsky D, Litinsky I, Elkayam O.
    Arthritis Rheum; 2006 Feb 15; 55(1):53-6. PubMed ID: 16463412
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
    Kapitány A, Szabó Z, Lakos G, Aleksza M, Végvári A, Soós L, Karányi Z, Sipka S, Szegedi G, Szekanecz Z.
    Isr Med Assoc J; 2008 Jan 15; 10(1):32-6. PubMed ID: 18300568
    [Abstract] [Full Text] [Related]

  • 8. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
    Snir O, Widhe M, von Spee C, Lindberg J, Padyukov L, Lundberg K, Engström A, Venables PJ, Lundeberg J, Holmdahl R, Klareskog L, Malmström V.
    Ann Rheum Dis; 2009 May 15; 68(5):736-43. PubMed ID: 18635594
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.
    van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR.
    Arthritis Rheum; 2006 Apr 15; 54(4):1117-21. PubMed ID: 16572446
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M.
    Mikrobiyol Bul; 2008 Oct 15; 42(4):669-74. PubMed ID: 19149089
    [Abstract] [Full Text] [Related]

  • 15. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK, Sheen DH, Lee YJ, Mun YR, Park M, Shim SC.
    J Rheumatol; 2009 Apr 15; 36(4):712-6. PubMed ID: 19286846
    [Abstract] [Full Text] [Related]

  • 16. Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis.
    Verpoort KN, van Gaalen FA, van der Helm-van Mil AH, Schreuder GM, Breedveld FC, Huizinga TW, de Vries RR, Toes RE.
    Arthritis Rheum; 2005 Oct 15; 52(10):3058-62. PubMed ID: 16200610
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T, Shimada K, Ozawa N, Hayakawa H, Hagiwara F, Nakayama H, Sugii S, Ozawa Y, Tohma S.
    J Rheumatol; 2006 Dec 15; 33(12):2390-7. PubMed ID: 16924694
    [Abstract] [Full Text] [Related]

  • 18. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.
    Huizinga TW, Amos CI, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D, Schreuder GM, Wener M, Breedveld FC, Ahmad N, Lum RF, de Vries RR, Gregersen PK, Toes RE, Criswell LA.
    Arthritis Rheum; 2005 Nov 15; 52(11):3433-8. PubMed ID: 16255021
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.